Raymond James & Associates’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,127	Closed	-$55.7K	–	4001
2023 Q1	$55.7K	Sell	6,127 -652	-10%	-$9.24K	﹤0.01%	3723
2022 Q4	$79.5K	Sell	6,779 -2,961	-30%	-$52.2K	﹤0.01%	3670
2022 Q3	$206K	Sell	9,740 -4,643	-32%	-$125K	﹤0.01%	3428
2022 Q2	$349K	Sell	14,383 -8,168	-36%	-$278K	﹤0.01%	3136
2022 Q1	$1.12M	Buy	22,551 +2,088	+10%	+$103K	﹤0.01%	2511
2021 Q4	$1.44M	Sell	20,463 -6,302	-24%	-$531K	﹤0.01%	2395
2021 Q3	$2.5M	Sell	26,765 -137	-0.5%	-$13K	﹤0.01%	1943
2021 Q2	$2.7M	Buy	26,902 +880	+3%	+$85.8K	﹤0.01%	1891
2021 Q1	$2.43M	Buy	26,022 +1,384	+6%	+$140K	﹤0.01%	1882
2020 Q4	$2.03M	Buy	24,638 +74	+0.3%	+$6.31K	﹤0.01%	1883
2020 Q3	$2.11M	Buy	24,564 +19,988	+437%	+$2.33M	﹤0.01%	1737
2020 Q2	$426K	Buy	4,576 +2,192	+92%	+$121K	﹤0.01%	2699
2020 Q1	$68K	Sell	2,384 -2,343	-50%	-$91.1K	﹤0.01%	3280
2019 Q4	$196K	Buy	+4,727	New	+$104K	﹤0.01%	3352